HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Richard Newmark Selected Research

Denosumab

5/2010Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates.
4/2010Denosumab prevents metacarpal shaft cortical bone loss in patients with erosive rheumatoid arthritis.
1/2009Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial.
5/2008Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Richard Newmark Research Topics

Disease

6Rheumatoid Arthritis
06/2015 - 05/2004
1Crohn Disease (Crohn's Disease)
11/2016
1Psoriatic Arthritis
06/2014
1Bone Resorption
01/2009
1Infections
05/2004
1Injection Site Reaction
05/2004
1Neutropenia
05/2004

Drug/Important Bio-Agent (IBA)

4Monoclonal AntibodiesIBA
11/2016 - 01/2009
4DenosumabFDA Link
05/2010 - 05/2008
3brodalumabIBA
11/2016 - 06/2014
3Methotrexate (Mexate)FDA LinkGeneric
06/2015 - 05/2004
2Interleukin-17 ReceptorsIBA
06/2015 - 06/2014
2Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
06/2004 - 05/2004
1Diphosphonates (Bisphosphonates)IBA
05/2010
1GlucocorticoidsIBA
05/2010
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
06/2004
1Etanercept (Enbrel)FDA Link
05/2004

Therapy/Procedure

1Therapeutics
05/2004